Profile picture

Professor Bertrand Cariou

Institut du Thorax, Inserm UMR 1087, Nantes (France)
Follow
Logo ESC

Contributor content

Open-label ODYSSEY APPRISE study: interim data from the first 843 participants
Presentation
Open-label ODYSSEY APPRISE study: interim data from the first 843 participants
Read more
Are there effects of PCSK9 inhibitors beyond cholesterol lowering?
Presentation
Are there effects of PCSK9 inhibitors beyond cholesterol lowering?
Read more

ESC 365 is supported by

novartis Explore sponsored resources